79975813 - KLARIFY

Information

  • Trademark
  • 79975813
  • Serial Number
    79975813
  • Filing Date
    February 11, 2022
    2 years ago
  • Transaction Date
    December 31, 2024
    4 days ago
  • Status Date
    December 12, 2024
    23 days ago
  • Published for Opposition Date
    November 12, 2024
    a month ago
  • Location Date
    October 10, 2024
    2 months ago
  • Status Code
    802
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    STRUCK, ROBERT
  • Attorney Docket Number
    3985.0080000
    Attorney Name
    Monica Riva Talley
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
5
Mark Identification
KLARIFY
Case File Statements
  • GS0091: computer software, namely downloadable computer software for medical use for assisting allergy and asthma patients and medical personnel in storing and handling patient data; diagnostic apparatus for testing food, namely, for mold detection; optical sensors for detecting and analyzing the presence of chemicals, toxins, mold and allergens in food, food components and food products; downloadable electronic publications in the nature of magazines and periodicals in the field of allergy and asthma; downloadable electronic magazines and periodicals in the field of allergy and asthma; online downloadable electronic questionnaires on medical issues relating to allergy and asthma; none of the aforesaid goods relating to the cardiovascular field nor for use in continence management, but all solely for use in relation to allergy and asthma
  • GS0381: Providing access, with or without subscription, to an e-commerce platform on the Internet giving users access to medical information in the allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic disease as well as atopic dermatitis and food allergy fields, namely, providing access to telecommunication networks; none of the aforesaid services in relation to the cardiovascular field nor in relation to continence management, but all in relation to allergy and asthma only
  • GS0051: Pharmaceutical and veterinary preparations for immunotherapeutic purposes for the treatment of autoimmune diseases; pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; diagnostic preparations for medical purposes, diagnostic reagents and diagnostic testing strips for medical use in the field of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; eye drops; nose drops, nasal sprays for medical purposes; pharmaceutical preparations for inhalers for the treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; ; probiotic preparations for medical and veterinary use; infant formula, namely, lactose free infant formula and hydrolyzed milk infant formula; additives for infant formula to prevent the development of allergies, namely, dietary supplements; food for babies; diagnostic testing materials for medical use, namely, diagnostic test patch for application to the skin for determining allergies; allergy and asthma testing kits, namely, diagnostic test patch for application to the skin for determining allergic reactions; none of the aforesaid goods for use in the cardiovascular field nor for use in continence management, but all solely for use in relation to allergy and asthma
  • GS0161: Printed matter, namely, printed calendars and forms; printed instructional and teaching materials except apparatus in the field of allergy and asthma; printed magazines and periodicals in the field of allergy and asthma; printed questionnaires on medical issues relating to allergy and asthma; none of the aforesaid goods relating to the cardiovascular field nor for use in continence management, but all solely for use in relation to allergy and asthma
  • PM0001: CLARIFY
  • GS0441: Medical services and medical healthcare services; medical consulting services, namely, counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases as well as atopic dermatitis, food allergy, and anaphylactic reactions; providing patient support relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases, atopic dermatitis, food allergy, and anaphylactic reactions, also electronically or digitally, including through a website with or without subscription, namely, medical consultations; providing medical information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases, atopic dermatitis, food allergy, and anaphylactic reactions, also electronically or digitally, including through a website; medical diagnostic services, namely, medical diagnostic testing, monitoring and reporting services; all of the aforesaid services in relation to allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis, food allergy, and anaphylactic reactions; none of the aforesaid services in relation to the cardiovascular field nor in relation to continence management, but all in relation to allergy and asthma only
  • GS0421: Scientific, technological, medical, and pharmacological research services and design relating thereto, namely, scientific research and technological research in the field of manufacturing processes, medical research, pharmaceutical research, pharmaceutical products development and new product design; scientific and medical laboratory services; medical and scientific research, namely, conducting clinical trials for others; computer services, namely, the creation of online communities for registered users to participate in discussions, and engage in social networking; providing a website featuring technology that enables consumers to form virtual communities, engage in social networking and share information regarding food, food components, and food products; all of the aforesaid services in relation to allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy; statistical investigations and statistical studies in the fields of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, respiratory allergic diseases as well as atopic dermatitis and food allergy, namely, medical research; none of the aforesaid services in relation to the cardiovascular field nor in relation to continence management, but all in relation to allergy and asthma only
Case File Event Statements
  • 7/30/2022 - 2 years ago
    2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI
  • 8/1/2022 - 2 years ago
    3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/5/2022 - 2 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 11/28/2022 - 2 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/30/2022 - 2 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/1/2022 - 2 years ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/30/2023 - a year ago
    9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/21/2023 - a year ago
    10 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/31/2023 - a year ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/31/2023 - a year ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/1/2023 - a year ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/8/2023 - a year ago
    14 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 7/28/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 1/30/2023 - a year ago
    8 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/8/2023 - a year ago
    15 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 9/8/2023 - a year ago
    16 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 1/3/2024 - a year ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/3/2024 - a year ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 1/21/2024 - 11 months ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 3/8/2024 - 10 months ago
    20 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 6/17/2024 - 6 months ago
    23 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 6/17/2024 - 6 months ago
    21 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 8/12/2024 - 4 months ago
    22 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 8/29/2024 - 4 months ago
    24 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 10/4/2024 - 3 months ago
    25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/23/2024 - 2 months ago
    26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/1/2024 - 2 months ago
    27 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 11/12/2024 - a month ago
    28 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/12/2024 - a month ago
    29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/12/2024 - 23 days ago
    30 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF